Table 1.
Demography and baseline vital parameters in patients randomized.
| Treatment | ITT dataset |
PP dataset |
|||||
|---|---|---|---|---|---|---|---|
| N | Mean (SD) | t (p)* | N | Mean (SD) | t (p)* | ||
| Age (yrs.) | Ashwagandha | 34 | 32.35 (9.53) | 0.026 (0.980) | 30 | 32.40 (8.02) | −0.258 (0.798) |
| Placebo | 34 | 32.29 (9.36) | 31 | 32.97 (9.13) | |||
| Height (cm.) | Ashwagandha | 34 | 164.96 (8.95) | 0.265 (0.792) | 30 | 165.25 (8.70) | −0.004 (0.997) |
| Placebo | 34 | 164.41 (7.95) | 31 | 165.26 (7.44) | |||
| Weight (kg.) | Ashwagandha | 34 | 62.63 (15.95) | −0.084 (0.934) | 30 | 63.03 (15.01) | 0.003 (0.997) |
| Placebo | 34 | 62.90 (10.11) | 31 | 63.02 (10.43) | |||
| BMI (Kg/sq.m) | Ashwagandha | 34 | 22.78 (4.52) | −0.557 (0.580) | 30 | 22.91 (4.42) | −0.215 (0.831) |
| Placebo | 34 | 23.34 (3.78) | 31 | 23.13 (3.83) | |||
|
N |
Count |
χ2(p)^ |
N |
Count |
χ2(p)^ |
||
| Gender (M/F) | Ashwagandha | 34 | 25/09 | 0.327 (0.567) | 30 | 23/07 | 0.144 (0.704) |
| Placebo | 34 | 27/07 | 31 | 25/06 | |||
^Chi-square test; * Independent sample t-test (between group comparisons).
ITT, Intent-to-treat; M, Male; F, Female; PP, Per-protocol; SD, Standard deviation.